Nucor (NUE) Competitors

ATI has a net margin of 10.09% compared to Nucor's net margin of 7.99%. ATI's return on equity of 29.27% beat Nucor's return on equity.

In the previous week, Nucor had 25 more articles in the media than ATI. MarketBeat recorded 41 mentions for Nucor and 16 mentions for ATI. Nucor's average media sentiment score of 1.43 beat ATI's score of 1.37 indicating that Nucor is being referred to more favorably in the media.

76.5% of Nucor shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 1.0% of ATI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Nucor has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market. Comparatively, ATI has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market.

Nucor presently has a consensus price target of $273.31, indicating a potential upside of 12.06%. ATI has a consensus price target of $232.00, indicating a potential upside of 12.16%. Given ATI's stronger consensus rating and higher possible upside, analysts plainly believe ATI is more favorable than Nucor.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

Nucor has a net margin of 7.99% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Nucor's return on equity.

In the previous week, Nucor had 35 more articles in the media than Cabot. MarketBeat recorded 41 mentions for Nucor and 6 mentions for Cabot. Cabot's average media sentiment score of 1.47 beat Nucor's score of 1.43 indicating that Cabot is being referred to more favorably in the news media.

Nucor has higher revenue and earnings than Cabot. Nucor is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

76.5% of Nucor shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 3.1% of Cabot shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nucor currently has a consensus target price of $273.31, indicating a potential upside of 12.06%. Cabot has a consensus target price of $89.00, indicating a potential upside of 4.58%. Given Nucor's stronger consensus rating and higher possible upside, analysts plainly believe Nucor is more favorable than Cabot.

Nucor has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Cabot has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Nucor pays out 17.9% of its earnings in the form of a dividend. Cabot pays out 53.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Nucor presently has a consensus price target of $273.31, indicating a potential upside of 12.06%. Chemours has a consensus price target of $20.10, indicating a potential upside of 25.94%. Given Chemours' higher probable upside, analysts clearly believe Chemours is more favorable than Nucor.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.2%. Nucor pays out 17.9% of its earnings in the form of a dividend. Chemours pays out -18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Nucor had 21 more articles in the media than Chemours. MarketBeat recorded 41 mentions for Nucor and 20 mentions for Chemours. Nucor's average media sentiment score of 1.43 beat Chemours' score of 0.65 indicating that Nucor is being referred to more favorably in the media.

Nucor has a net margin of 7.99% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Nucor's return on equity.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Nucor has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market. Comparatively, Chemours has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

In the previous week, Nucor had 32 more articles in the media than Celanese. MarketBeat recorded 41 mentions for Nucor and 9 mentions for Celanese. Nucor's average media sentiment score of 1.43 beat Celanese's score of 1.04 indicating that Nucor is being referred to more favorably in the media.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 98.9% of Celanese shares are owned by institutional investors. 0.6% of Nucor shares are owned by insiders. Comparatively, 0.3% of Celanese shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Nucor has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Celanese has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Nucor has a net margin of 7.99% compared to Celanese's net margin of -12.04%. Celanese's return on equity of 13.04% beat Nucor's return on equity.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Nucor pays out 17.9% of its earnings in the form of a dividend. Celanese pays out -1.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor presently has a consensus target price of $273.31, indicating a potential upside of 12.06%. Celanese has a consensus target price of $63.47, indicating a potential upside of 35.44%. Given Celanese's higher probable upside, analysts clearly believe Celanese is more favorable than Nucor.